NRP1 and neoplasm: Additionally, PLT-combined administration with ginsenoside compound K (CK), using the tumor-targeting carriers tLyp1 liposomes, was found to enhance tissue penetration and selectively target neuropilin-1 on the surface of lung cancer cells, thus facilitating the delivery of PTL and CK to the tumor.